Automatic Data Processing

ADP · NASDAQ

$292.75+$5.72 (+1.99%)TodayMarket closed ·
Prev close $287.03

ADP analyst rating

HoldConsensus of 11 analysts over the last 12 months. 27% rate it a buy.
  • Strong buy0
  • Buy3
  • Hold6
  • Underperform2
  • Sell0

12-month price target · 18 analysts

Average $291.40 (−0.5% downside)

Low
$227.25
Now
$292.75
High
$338.10

Upgrades and downgrades

The latest rating actions, newest first

ADP analyst upgrades, downgrades and rating actions
FirmDateActionRating
Cantor FitzgeraldAug 5, 2026MaintainsOverweight
Cantor FitzgeraldAug 3, 2026MaintainsOverweight
CitigroupJul 30, 2026MaintainsNeutral
Morgan StanleyJul 30, 2026MaintainsEqual-Weight
StifelJul 30, 2026MaintainsHold
Wells FargoJul 30, 2026MaintainsEqual-Weight
GuggenheimJul 30, 2026MaintainsBuy
UBSJul 22, 2026MaintainsNeutral
Cantor FitzgeraldJul 22, 2026MaintainsOverweight
GuggenheimJul 21, 2026MaintainsBuy

The case for and against

Updated Oct 14, 2026

Bull case

Automatic Data Processing is supported by a durable recurring-revenue model, a compliance moat across 140 countries, and payroll infrastructure that is difficult to replicate, all of which are reinforced by its scale serving over 1.1 million clients and 42 million workers. The business appears well positioned to finish FY26 toward the high end of Employer Services guidance, with broad-based strength, stable hiring trends, and New ARR momentum suggesting revenue growth can remain resilient even in a choppy macro backdrop. Pricing realization, higher win rates from a flight to safety, improving Lyric and large-enterprise traction, and continued margin expansion from AI-driven productivity and client-funds income all support a constructive fundamental outlook.

Bear case

Automatic Data Processing is facing a less attractive setup because its FY26 Employer Services growth appears increasingly dependent on a strong F4Q26 booking outcome, yet the company’s wide 4%-7% bookings range highlights meaningful execution risk and volatility around whether large enterprise deals close by June. Even with supportive pricing, employment, and float revenue, rising healthcare premiums and mix pressure in PEO could lower margins, while management has already noted modest softening in PEO same-store hiring and outsized healthcare inflation. The stock’s fundamentals therefore look vulnerable if New ARR and retention slow, especially as analysts model FY27 PEO growth decelerating to 5.5% from 6.6% in FY26.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.